Evidence map›Paper›PMID 23147561›Full record

ArticleMolecular immunology2013

Human CD4 T cell epitopes selective for Vaccinia versus Variola virus.

Alicia Probst, Aurore Besse, Emmanuel Favry, Gilles Imbert, Valérie Tanchou, Florence Anne Castelli, Bernard Maillere

Open access · greenAbstract read
In one paragraph

Article in Molecular immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Alicia ProbstCEA, iBiTecS, Service d'Ingénierie Moléculaire des Protéines, Labex LERMIT, Labex VRI, Gif Sur Yvette F-91191, France.
Aurore Besse
Emmanuel Favry
Gilles Imbert
Valérie Tanchou
Florence Anne Castelli
Bernard Maillere
Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRLaboratoire d'Excellence en Recherche sur le Médicament et l'Innovation ThérapeutiqueCEA Marcoule · FRInstitut de Recherche Vaccinale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the high degree of sequence identity between Orthopoxvirus species, the specific B and T cell responses raised against these viruses are largely cross-reactive and poorly selective. We therefore searched for CD4 T cell epitopes present in the conserved parts of the Vaccinia genome (VACV) but absent from Variola viruses (VARV), with a view to identifying immunogenic sequences selective for VACV. We identified three long peptide fragments from the B7R, B10R and E7R proteins by in silico comparisons of the poxvirus genomes, and evaluated the recognition of these fragments by VACV-specific T cell lines derived from healthy donors. For the 12 CD4 T cell epitopes identified, we assessed their binding to common HLA-DR allotypes and their capacity to induce peptide-specific CD4 T-cell lines. Four peptides from B7R and B10R displayed a broad binding specificity for HLA-DR molecules and induced multiple T cell lines from healthy donors. Besides their absence from VARV, the two B10R peptide sequences were mutated in the Cowpox virus and completely absent from the Monkeypox genome. This work contributes to the development of differential diagnosis of poxvirus infections.

Indexed as

Genome, ViralAmino Acid SequenceCD4-Positive T-LymphocytesCell LineComputer SimulationEpitopesEpitopes, T-LymphocyteHLA-DR AntigensHumansMolecular Sequence DataProtein BindingVaccinia virusVariola virusEpitopesEpitopes, T-LymphocyteHLA-DR Antigens

Identifiers

PMID23147561
PMCPMC9528225
OpenAlexW2027885077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.